Eli Lilly and Company vs Roche Holding AG
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Eli Lilly and Company is the larger company by market value: $1.20 T against $370.3 B for Roche Holding AG, 3.2 times as much (market caps of Oct 26, 2026 for Eli Lilly and Company and Aug 1, 2026 for Roche Holding AG). Roche Holding AG's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Roche Holding AG had more revenue: $67.0 B in the year to December 2023 against $65.2 B for Eli Lilly and Company in the year to December 2025.
- Eli Lilly and Company earned more: net income of $20.6 B against $12.7 B for Roche Holding AG.
- Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 19.0% for Roche Holding AG.
- Roche Holding AG employs more people: 103,613 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,303,580 of revenue at Eli Lilly and Company and $646,705 at Roche Holding AG.
- On price to earnings, Eli Lilly and Company trades at 43.4× and Roche Holding AG at 29.1×: investors pay more for each dollar of Eli Lilly and Company's profit.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Eli Lilly and Company LLY · #13 in the world | Roche Holding AG ROG.SW · #38 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇨🇭 Switzerland |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1876 | 1896 |
| Size | ||
| Market cap | $1.20 T | $370.3 B |
| Revenue | $65.2 B | $67.0 B |
| Net income | $20.6 B▲ best | $12.7 B |
| Employees | 50,000 | 103,613 |
| Valuation | ||
| P/E ratio | 43.4× | 29.1× |
| Price to sales | 13.9× | 5.5× |
| Price to book | 45.1× | 10.0× |
| Profitability | ||
| Gross margin | 83.0% | — |
| Net margin | 31.7% | — |
| Return on equity | 101.2% | — |
| Growth | ||
| Revenue growth | 44.7% | — |
| Revenue growth, 3 years a year | 31.7% | — |
| Earnings per share growth | 96.0% | — |
| Financial strength | ||
| Debt to equity | 1.5× | — |
| Shareholder returns | ||
| Dividend yield | 0.5% | — |
| Shareholder yield | 0.8% | — |
| Strength scores | ||
| Piotroski F-score | 7 of 9 | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Eli Lilly and Company or Roche Holding AG?
Eli Lilly and Company is the larger company by market value: $1.20 T against $370.3 B for Roche Holding AG, 3.2 times as much (market caps of Oct 26, 2026 for Eli Lilly and Company and Aug 1, 2026 for Roche Holding AG). Roche Holding AG's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Eli Lilly and Company or Roche Holding AG?
Roche Holding AG had more revenue: $67.0 B in the year to December 2023 against $65.2 B for Eli Lilly and Company in the year to December 2025. Eli Lilly and Company earned more: net income of $20.6 B against $12.7 B for Roche Holding AG.
Which is more profitable, Eli Lilly and Company or Roche Holding AG?
Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 19.0% for Roche Holding AG.
Which has more employees, Eli Lilly and Company or Roche Holding AG?
Roche Holding AG employs more people: 103,613 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,303,580 of revenue at Eli Lilly and Company and $646,705 at Roche Holding AG.
Is Eli Lilly and Company cheaper than Roche Holding AG?
On price to earnings, Eli Lilly and Company trades at 43.4× and Roche Holding AG at 29.1×: investors pay more for each dollar of Eli Lilly and Company's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
More about Eli Lilly and Company
- Eli Lilly and Company: company page
- Who owns Eli Lilly and Company?
- Eli Lilly and Company market cap history
- Eli Lilly and Company revenue by year
- How many employees does Eli Lilly and Company have?
- Is Eli Lilly and Company cheap or expensive?
- Eli Lilly and Company against its peers: ranks and percentiles
More about Roche Holding AG
Sources#
Every figure on this page comes from these, with the date shown next to it.